Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
...tform technology. Based on this positive outcome, lpath will collaborate with DataMabs of London, England,... an antibody against another bioactive lipid, S1P. lpath humanized the antibody in 2006 and plans to file a...eutics as an important new area of drug discovery. lpath was one of the first companies to recognize that b...Lpath Demonstrates 'First-in-Class' AMD Results With Its Lead Drug Candidate, Sphingomab
...tributes significantly to AMD-related vision loss. lpath has demonstrated in previous studies that Sphingom... is extremely well positioned in the AMD arena." lpath plans to initiate clinical trials for wet AMD in early 2008. About lpath Lpath, Inc., headquartered in San Diego, Califor...AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs
..., has directed research and development programs for a number of early stage biotech companies such as Centaur Pharmaceuticals, Atairgin Technologies, lpath Therapeutics, Inc. (LPTN.OB) and Tosk in addition to AngioGenex. He was also instrumental in raising capital for those companies. His career highlight...